Compare ResMed Inc. (RMD) vs Synopsys, Inc. (SNPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs Synopsys, Inc. — how do they compare? ResMed Inc. trades at $196 (market cap $28.81B), while Synopsys, Inc. trades at $388.58 (market cap $72.47B). The key difference: Synopsys, Inc. is far larger — about 2.5× ResMed Inc.'s market cap, and ResMed Inc. pays a 1.21% dividend while Synopsys, Inc. pays none. Which is the better fit depends on your goals.
| RMD | SNPS | |
|---|---|---|
Market Cap | $28.81B | $72.47B |
Sector | Health | Technology |
52-Week High | $293.73 | $645.59 |
52-Week Low | $182.82 | $378.46 |
Enterprise Value | $27.99B | $80.82B |
Dividend Yield | 1.21% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About Synopsys, Inc.
Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Read more on SNPS →
